Independent testing verdict Fail
This product failed independent verification.
Sample failed verification: 58.1% measured purity against a ≥98% claim, with 98.4% of labelled content.
- Identity verified
- No
- Measured purity
- 58.1%
- Content accuracy
- 98.4%
- Test recency
- Current cycle
The labelled compound was not confirmed
Label claimed ≥98%
4.92mg measured against 5mg claimed
Published 3 months ago
Specimen PI-LAB-2026-116 Tested by Redpoint Laboratories 9 samples tested from this company Purity & Testing score 9/100
Full laboratory evidence Findings table, methodology, chain of custody and the original report
Findings
| Metric | Label claim | Measured | Assessment |
|---|---|---|---|
| Purity (HPLC) | ≥ 98% | 58.1% | Fails claim |
| Identity (MS) | Semaglutide | Not confirmed | Identity failure |
| Content | 5 mg | 4.92 mg | Within 5% of label |
Methodology & chain of custody
Reversed-phase HPLC purity analysis with UV detection at 214nm.
The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Redpoint Laboratories. See our full testing methodology.
- Lot / batch
- D3001-26
- Purchased
- Analysed
- Published
- Laboratory
- Redpoint Laboratories
- Test type
- Full panel (purity, identity, content, endotoxin)
Testing notes
Result confirmed on a second sample from a separate lot at a second laboratory before publication.
Original laboratory report: PI-LAB-2026-116-report.pdf